| Equity |
Equity Dividends On February 7, 2024, the Board of Directors declared a cash dividend of $0.45 per share ($0.8 billion) with respect to the first half of fiscal 2024, which was paid in July 2024 to shareholders of record as of July 8, 2024. On November 30, 2023, the Board of Directors declared a cash dividend of $0.30 per share ($0.5 billion) with respect to the second half of fiscal 2023, which was paid in January 2024 to shareholders of record as of December 11, 2023. The Company did not declare or pay a dividend with respect to fiscal 2022 operations. Share Repurchase Program Effective February 7, 2024, the Board of Directors authorized the Company to repurchase a total of 400 million shares of its common stock. During the year ended September 28, 2024, the Company repurchased 28 million shares of its common stock for $3.0 billion (excluding the one percent excise tax on stock repurchases imposed by the Inflation Reduction Act of 2022). As of September 28, 2024, the Company had remaining authorization in place to repurchase approximately 372 million additional shares. The repurchase program does not have an expiration date. The following table summarizes the changes in each component of accumulated other comprehensive income (loss) (AOCI) including our proportional share of equity method investee amounts: | | | | | | | | | | | | | | | | | | | | | | | | | | Market Value Adjustments for Hedges | | Unrecognized Pension and Postretirement Medical Expense | | Foreign Currency Translation and Other | | AOCI | | | | | | AOCI, before tax | | | | | | | | | Balance at October 2, 2021 | $ | (152) | | | $ | (7,025) | | | $ | (1,047) | | | $ | (8,224) | | Unrealized gains (losses) arising during the period | 1,098 | | | 2,635 | | | (967) | | | 2,766 | | | Reclassifications of net (gains) losses to net income | (142) | | | 620 | | | — | | | 478 | | | | | | | | | | | Balance at October 1, 2022 | $ | 804 | | | $ | (3,770) | | | $ | (2,014) | | | $ | (4,980) | | | Unrealized gains (losses) arising during the period | (101) | | | 1,594 | | | (2) | | | 1,491 | | | Reclassifications of net (gains) losses to net income | (444) | | | 4 | | | 42 | | | (398) | | | Balance at September 30, 2023 | $ | 259 | | | $ | (2,172) | | | $ | (1,974) | | | $ | (3,887) | | Unrealized gains (losses) arising during the period | (112) | | | 25 | | | 119 | | | 32 | | Reclassifications of net (gains) losses to net income | (466) | | | (96) | | | — | | | (562) | | | Balance at September 28, 2024 | $ | (319) | | | $ | (2,243) | | | $ | (1,855) | | | $ | (4,417) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | Market Value Adjustments for Hedges | | Unrecognized Pension and Postretirement Medical Expense | | Foreign Currency Translation and Other | | AOCI | | | | | | Tax on AOCI | | | | | | | | | Balance at October 2, 2021 | $ | 42 | | | $ | 1,653 | | | $ | 89 | | | $ | 1,784 | | Unrealized gains (losses) arising during the period | (254) | | | (608) | | | 50 | | | (812) | | | Reclassifications of net (gains) losses to net income | 33 | | | (144) | | | — | | | (111) | | | | | | | | | | | Balance at October 1, 2022 | $ | (179) | | | $ | 901 | | | $ | 139 | | | $ | 861 | | Unrealized gains (losses) arising during the period | 12 | | | (384) | | | 17 | | | (355) | | Reclassifications of net (gains) losses to net income | 103 | | | — | | | (14) | | | 89 | | | Balance at September 30, 2023 | $ | (64) | | | $ | 517 | | | $ | 142 | | | $ | 595 | | Unrealized gains (losses) arising during the period | 27 | | | (10) | | | (26) | | | (9) | | Reclassifications of net (gains) losses to net income | 108 | | | 24 | | | — | | | 132 | | | Balance at September 28, 2024 | $ | 71 | | | $ | 531 | | | $ | 116 | | | $ | 718 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | Market Value Adjustments for Hedges | | Unrecognized Pension and Postretirement Medical Expense | | Foreign Currency Translation and Other | | AOCI | | | | | | AOCI, after tax | | | | | | | | | Balance at October 2, 2021 | $ | (110) | | | $ | (5,372) | | | $ | (958) | | | $ | (6,440) | | Unrealized gains (losses) arising during the period | 844 | | | 2,027 | | | (917) | | | 1,954 | | | Reclassifications of net (gains) losses to net income | (109) | | | 476 | | | — | | | 367 | | | | | | | | | | | Balance at October 1, 2022 | $ | 625 | | | $ | (2,869) | | | $ | (1,875) | | | $ | (4,119) | | Unrealized gains (losses) arising during the period | (89) | | | 1,210 | | | 15 | | | 1,136 | | Reclassifications of net (gains) losses to net income | (341) | | | 4 | | | 28 | | | (309) | | | Balance at September 30, 2023 | $ | 195 | | | $ | (1,655) | | | $ | (1,832) | | | $ | (3,292) | | Unrealized gains (losses) arising during the period | (85) | | | 15 | | | 93 | | | 23 | | Reclassifications of net (gains) losses to net income | (358) | | | (72) | | | — | | | (430) | | | Balance at September 28, 2024 | $ | (248) | | | $ | (1,712) | | | $ | (1,739) | | | $ | (3,699) | |
Details about AOCI components reclassified to net income are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | Gains (losses) in net income: | | Affected line item in the Consolidated Statements of Operations: | | 2024 | | 2023 | | 2022 | Market value adjustments, primarily cash flow hedges | | Primarily revenue | | $ | 466 | | | $ | 444 | | | $ | 142 | | | Estimated tax | | Income taxes | | (108) | | | (103) | | | (33) | | | | | | 358 | | | 341 | | | 109 | | | | | | | | | | | | | | | | | | | | Pension and postretirement medical expense | | Interest expense, net | | 96 | | | (4) | | | (620) | | | Estimated tax | | Income taxes | | (24) | | | — | | | 144 | | | | | | 72 | | | (4) | | | (476) | | | | | | | | | | | Foreign currency translation and other | | Other income (expense), net | | — | | | (42) | | | — | | Estimated tax | | Income taxes | | — | | | 14 | | | — | | | | | | — | | | (28) | | | — | | | | | | | | | | | Total reclassifications for the period | | | | $ | 430 | | | $ | 309 | | | $ | (367) | |
|